Benzylhydrochlorothiazide

苄基氢氯噻嗪

Report date: 2022/02/14 09:54:37
NME

Base Information

Drug NameBenzylhydrochlorothiazide
Drug Alias NameBehyd
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersChloride channel agonists
TargetsPotassium channelChloride channel
Therapy Area/IndicationsEdemaHypertensionHeart Failure
Global Approved IndicationsEdemaHypertensionHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1961/01/31
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Holdings Inc
Inactive CompaniesN/A
Active IndicationsEdemaHypertensionHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC02DA
Related LinksKEGG